COMMUNIQUÉ DE PRESSE publié le 06/03/2024 à 06:05, il y a 2 années 3 mois AI/ML Innovations Inc.’s Health Gauge Launches "Follow Your Heart": A Revolutionary Non-Invasive Blood Pressure Measurement Solution Health Gauge Inc. announces the commercial launch of 'Follow Your Heart,' a smartwatch with medical-grade accuracy for blood pressure monitoring. The product caters to individuals managing hypertension and aims to provide reliable and accessible monitoring solutions Health Gauge Inc. Smartwatch Blood Pressure Monitoring Follow Your Heart Hypertension
BRÈVE publiée le 04/03/2024 à 14:45, il y a 2 années 3 mois AI/ML Innovations Inc. Welcomes Esmat Naikyar as Interim Chief Product Officer to Drive Healthcare Innovation Artificial Intelligence Healthcare Technology AI/ML Innovations Inc. Esmat Naikyar Neural Networks
BRÈVE publiée le 04/03/2024 à 14:45, il y a 2 années 3 mois AI/ML Innovations Inc. accueille Esmat Naikyar au poste de directeur des produits par intérim pour stimuler l'innovation dans le domaine des soins de santé AI/ML Innovations Inc. Intelligence Artificielle Technologie De La Santé Esmat Naikyar Les Réseaux De Neurones
COMMUNIQUÉ DE PRESSE publié le 04/03/2024 à 14:40, il y a 2 années 3 mois AI/ML Innovations Inc. Welcomes Esmat Naikyar as Interim Chief Product Officer to Drive Healthcare Innovation AI/ML Innovations Inc. announces Esmat Naikyar as Interim Chief Product Officer, steering the Company towards ambitious goals in AI & ML healthcare products. Naikyar's expertise adds value to the team Healthcare Technology AI/ML Innovations Inc. Esmat Naikyar Neural Networks Interim Chief Product Officer
BRÈVE publiée le 27/02/2024 à 14:30, il y a 2 années 3 mois Avancée Majeure dans la Mesure de la Pression Artérielle par AI/ML Innovations AI/ML Innovations Health Gauge Mesure De La Pression Artérielle FDA 510(k) Classe II Technologie EdgeAI
BRÈVE publiée le 27/02/2024 à 14:30, il y a 2 années 3 mois Major Advance in Blood Pressure Measurement by AI/ML Innovations AI/ML Innovations Health Gauge Blood Pressure Measurement FDA 510(k) Class II EdgeAI Technology
COMMUNIQUÉ DE PRESSE publié le 27/02/2024 à 14:30, il y a 2 années 3 mois AI/ML Innovations Inc.'s Health Gauge Seeking FDA Approval for Its Patented Blood Pressure Measurement Technology AI/ML Innovations Inc. subsidiary, Health Gauge, achieves FDA 510(k) Class II certification for Blood Pressure Measurement Neural Network. Launching 'Follow Your Heart' smartwatch with medical grade accuracy FDA AI/ML Innovations Inc. Health Gauge 510(k) Class II Blood Pressure Measurement Neural Network
COMMUNIQUÉ DE PRESSE publié le 14/02/2024 à 14:30, il y a 2 années 4 mois AI/ML Innovations Inc. Appoints Dr. David Cramb, Dean of the Faculty of Science at Toronto Metropolitan University, as Chair of the Company's Inaugural Science and Product Advisory Board Dr. David Cramb appointed Chair of AI/ML Innovations Inc.'s Science and Product Advisory Board, driving innovation in healthcare through AI and ML technologies Artificial Intelligence AI/ML Innovations Inc. Machine Learning Dr. David Cramb Health Tech Sector
COMMUNIQUÉ DE PRESSE publié le 08/02/2024 à 22:10, il y a 2 années 4 mois AI/ML Innovations Inc. Presents A Fireside Chat and a Company Update AI/ML Innovations Inc. presents a fireside chat with Paul Duffy and Hassan Kham, discussing the MicroPay partnership and a corporate update focusing on the Pulse Whisperer and Long Covid Pilot Program AI/ML Innovations Inc. Pulse Whisperer Fireside Chat MicroPay Partnership Long Covid Pilot Program
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 14:30, il y a 2 années 4 mois AI/ML Innovations Inc. Unveils Micropayment Pilot Program in Collaboration With TODAQ Micro and Health Gauge Biometrics Health Gauge Inc. launches Pilot Program with TODAQ Micro's Micropayment Platform for affordable and convenient healthcare access. The program focuses on using micropayments for accessing Blood Pressure Measurements through AI-powered Biometrics Platform Health Gauge Inc. TODAQ Micro Micropayments Healthcare Access AI-powered Biometrics Platform
Publié le 19/06/2026 à 19:33, il y a 1 jour 19 heures Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Publié le 19/06/2026 à 19:33, il y a 1 jour 19 heures Disclosure of transactions in own shares from June 15 to June 19, 2026
Publié le 19/06/2026 à 19:23, il y a 1 jour 19 heures Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Publié le 19/06/2026 à 19:23, il y a 1 jour 19 heures Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Publié le 20/06/2026 à 01:00, il y a 1 jour 13 heures Onco-Innovations Announces Non-Brokered LIFE Offering
Publié le 20/06/2026 à 00:00, il y a 1 jour 14 heures Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Publié le 19/06/2026 à 04:30, il y a 2 jours 10 heures Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Publié le 19/06/2026 à 01:20, il y a 2 jours 13 heures American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Publié le 19/06/2026 à 01:07, il y a 2 jours 13 heures Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Publié le 20/06/2026 à 21:25, il y a 17 heures 32 minutes VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Publié le 20/06/2026 à 06:00, il y a 1 jour 8 heures Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Publié le 19/06/2026 à 20:17, il y a 1 jour 18 heures 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Publié le 19/06/2026 à 20:17, il y a 1 jour 18 heures 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Publié le 19/06/2026 à 19:01, il y a 1 jour 19 heures Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting